| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8771780 | The Journal of Urology | 2018 | 24 Pages |
Abstract
The benefit of lymphadenectomy in patients undergoing surgery for high risk renal cell carcinoma remains uncertain. Future strategies to answer this question should include a prospective trial in which patients with high risk renal cell carcinoma are randomized to specific lymphadenectomy templates.
Keywords
EORTCACRINLNDDFSECoGRCCAssureAJCCAdjuvantLymph node excisiondisease-free survivaloverall survivalLymph node dissectionEuropean Organisation for Research and Treatment of CancerRenal celleastern cooperative oncology groupChemotherapyMortalityRenal cell carcinomaCarcinomaAmerican College of Radiology Imaging NetworkKidneyAmerican Joint Committee on Cancer
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Benjamin T. Ristau, Judi Manola, Naomi B. Haas, Daniel Y.C. Heng, Edward M. Messing, Christopher G. Wood, Christopher J. Kane, Robert S. DiPaola, Robert G. Uzzo,